Beyond MRI Dye: Can Synthetic Contrast Match Gadolinium’s Accuracy? Key Takeaways Magnetic resonance imaging has been transformed by the introduction of gadolinium based contrast agents, which have served as the gold standard for enhancing tissue visualization for more than three decades. Over the
Author: Nancy Ogbonna
Endometriosis: Novel Medical Therapies Beyond GnRH Agonists
Endometriosis Novel Medical Therapies Beyond GnRH Agonists Abstract Endometriosis affects an estimated 10 to 15 percent of women of reproductive age and remains one of the most complex and therapeutically challenging conditions in gynecology. Characterized by the presence of endometrial-like tissue outside the uterine
Hypotension Prediction Index and Machine Learning: Game Changer or Gimmick?
Hypotension Prediction Index and Machine Learning Game Changer or Gimmick Abstract Intraoperative and critical care hypotension is independently associated with adverse outcomes, including acute kidney injury, myocardial injury, stroke, prolonged hospitalization, and increased mortality. Even brief episodes of mean arterial pressure below established thresholds have been
mRNA Vaccines Beyond COVID-19: What’s Next for Infectious Diseases?
mRNA Vaccines Beyond COVID-19 What’s Next for Infectious Diseases Abstract Messenger RNA vaccine technology came to global prominence during the COVID 19 pandemic, when rapid design, large scale manufacturing, and emergency authorization demonstrated the practical viability of this platform. Unlike traditional vaccines that rely on attenuated pathogens,
Predicting Rheumatoid Arthritis Treatment Success: New Biomarker Breakthrough
Predicting Rheumatoid Arthritis Treatment Success New Biomarker Breakthrough Key Takeaways Rheumatoid arthritis is a chronic systemic autoimmune disease affecting approximately 1 percent of the global population. Despite major advances in biologic and targeted synthetic disease modifying antirheumatic drugs, treatment success remains highly variable. Approximately
The New Margin Wars in Oncology: Less Is More…Until It Isn’t
Artificial Blood and Oxygen Carriers: The Next Revolution in Intraoperative Safety
Artificial Blood and Oxygen Carriers The Next Revolution in Intraoperative Safety Abstract The development of artificial blood and oxygen carrying substitutes represents a significant milestone in perioperative medicine, offering potential solutions to persistent challenges surrounding blood transfusion safety, supply constraints, and compatibility. Although allogeneic blood transfusion remains a
Comorbid Insomnia: New Research Reveals Bidirectional Mental Health Links
Comorbid Insomnia New Research Reveals Bidirectional Mental Health Links Introduction Comorbid insomnia represents a substantial and often underrecognized public health challenge, affecting an estimated 25 million individuals in the United States each year and contributing to approximately $100 billion in annual healthcare expenditures. Sleep
Platelet Function Testing vs Standard Care: What Clinical Data Really Shows
Platelet Function Testing vs Standard Care What Clinical Data Really Shows Introduction High on treatment platelet reactivity remains a significant clinical challenge in patients receiving clopidogrel, with approximately one in three treated individuals demonstrating inadequate platelet inhibition. This variability in response has important therapeutic
Targeting α-Synuclein: The Next Frontier in Parkinson’s Therapy
Targeting α-Synuclein The Next Frontier in Parkinson’s Therapy Abstract Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease, affecting an estimated 10 million individuals worldwide. Its prevalence is expected to rise substantially with population aging, creating an expanding clinical and socioeconomic
